CardioGenics Holdings Inc. is focused on technology and products targeting the immunoassay segment of the In-Vitro Diagnostic testing market. The Company has developed the QL Care Analyzer, a point-of-care immuno-analyzer, which is capable of running approximately 200+immunoassay diagnostic tests, such as cardiovascular diagnostic tests. As part of its technology, the Company has also developed a method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improves instrument sensitivity to light.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume

Delayed Quote OTC Markets

More quotes

Delayed OTC Markets 23:06:57 26/08/2026 +04			5-day change	1st Jan Change
0.000100 ^USD	0.00%		0.00%	+9,900.00%

10/09/21	Cardiogenics Holdings Inc Announces A Record Date Change for Its Dividend Distribution	CI
04/09/21	CardioGenics Holdings Inc. Announces License Agreement	CI

Market Cap	382K 328K 308K 281K 531K 36.45M 533K 3.64M 1.41M 18.39M 1.43M 1.4M 60.91M	P/E 2014	-2.3x	P/E 2015	-2.17x
Enterprise Value	539K 462K 434K 396K 748K 51.38M 752K 5.14M 1.99M 25.92M 2.02M 1.98M 85.85M	EV / Sales 2014	-	EV / Sales 2015	-
Free-Float	97.49%	Yield 2014 *	-	Yield 2015	-

10/09/21	Cardiogenics Holdings Inc Announces A Record Date Change for Its Dividend Distribution	CI
04/09/21	CardioGenics Holdings Inc. Announces License Agreement	CI
02/11/15	CardioGenics Holdings Inc completed the acquisition of substantially all of the assets of Plasticap Inc.	CI
05/10/15	CardioGenics Holdings Inc entered into a non-binding letter of intent to acquire substantially all of the assets of Plasticap Inc.	CI
13/01/15	CardioGenics Holdings Inc. Appoints Karim Murabet as Director	CI
27/09/13	CardioGenics Holdings Inc Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2013	CI
21/08/13	CardioGenics Holdings Inc Announces Commencement of Beta-Site Testing	CI
05/06/13	CardioGenics Holdings Inc Announces Internal Review Board Approval for Beta-Site Testing	CI
03/06/13	CardioGenics Holdings Inc announced that it has received $0.66 million in funding.	CI
31/05/13	CardioGenics Holdings Inc announced that it expects to receive $1.5 million in funding.	CI
01/03/13	CardioGenics Holdings Inc. Announces Demise of Director, Alexander D. G. Reid	CI
27/02/13	CardioGenics Holdings Inc. announced that it expects to receive $1 million in funding.	CI
17/04/12	CardioGenics Holdings Inc has Changed its Ticker to CGNH from CGNHE	CI

29/09/21	UPDATED: CARDIOGENICS HOLDINGS INC. ANNOUNCES A RECORD DATE CHANGE FOR ITS DIVIDEND DISTRIBUTION	AQ
10/09/21	CARDIOGENICS : ANNOUNCES A RECORD DATE CHANGE FOR ITS DIVIDEND DISTRIBUTION	AQ
04/09/21	CARDIOGENICS : ANNOUNCES LICENSE AGREEMENT AND DIVIDEND DISTRIBUTION	AQ
04/11/15	CardioGenics : Enters Into Asset Purchase Agreement to Acquire All Assets of Ontario-Based Plasticap	MW
05/10/15	CardioGenics : Enters Into Binding Letter of Intent to Acquire Assets of Ontario-Based Plasticap	MW

CardioGenics Holdings Inc Stock

Stocks

CGNH

US14160X2036

Medical Equipment, Supplies & Distribution

Valuation : CardioGenics Holdings Inc

Chart: CardioGenics Holdings Inc

Latest news : CardioGenics Holdings Inc

Press Releases : CardioGenics Holdings Inc

Quotes and Performance

Price Extremes

Managers and Directors : CardioGenics Holdings Inc

Diagnostic & Testing Substances

Financials

Company Profile

Quotes

Current month	+9,900.00%
1 month	+9,900.00%
6 months	+9,900.00%
Current year	+9,900.00%

1 week	0		0
1 month	0		0
Current year	0		0
1 year	0		0
3 years	0		0
5 years	0		0.08
10 years	0		0.29

Manager	Title	Age	Since
Yahia A. Gawad CEO	Chief Executive Officer	68	27/10/2009
James A. Essex DFI	Director of Finance/CFO	78	16/06/2010
Linda J. Sterling IRC	Investor Relations Contact	65	-

Director	Title	Age	Since
Julian Neil Tabatznik CHM	Chairman	76	16/06/2010
Yahia A. Gawad BRD	Director/Board Member	68	06/04/2011
Linda J. Sterling BRD	Director/Board Member	65	16/06/2010

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CARDIOGENICS HOLDINGS INC	0.00%	0.00%	+9,900.00%	0.00%	14.29K
GUARDANT HEALTH, INC.	-0.60%	+1.32%	+167.86%	+345.03%	22.94B
BIOMÉRIEUX	+1.28%	+0.80%	-36.81%	-21.80%	10.19B
10X GENOMICS, INC.	+0.02%	+1.01%	+360.16%	+36.57%	8.37B
CARIS LIFE SCIENCES, INC.	+0.84%	+8.54%	-30.19%	-	7.58B
LANTHEUS HOLDINGS, INC.	+0.06%	+0.57%	+77.36%	+51.82%	6.58B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-0.12%	-3.82%	-14.67%	-10.78%	6.02B
DIASORIN S.P.A.	+1.19%	+2.52%	-10.07%	-19.15%	4.36B
ANDON HEALTH CO., LTD.	-2.48%	-11.72%	+56.86%	+98.49%	4.19B
AUTOBIO DIAGNOSTICS CO., LTD.	+0.26%	-0.55%	-19.52%	-24.57%	2.84B
Average	-0.04%	+2.02%	+1,045.10%	+50.62%	7.31B
Weighted average by Cap.	-0.12%	+3.40%	+93.35%	+130.29%

	2014	2015
Net sales	-	-
Net income	-2.68M -2.3M -2.16M -1.97M -3.72M -256M -3.74M -25.55M -9.9M -129M -10.06M -9.84M -427M	-1.92M -1.64M -1.54M -1.41M -2.66M -183M -2.67M -18.27M -7.08M -92.21M -7.2M -7.04M -305M
Net Debt	132K 114K 107K 97.3K 184K 12.61M 185K 1.26M 489K 6.36M 497K 486K 21.08M	157K 134K 126K 115K 217K 14.93M 218K 1.49M 578K 7.53M 588K 575K 24.94M